LKT Labs

Biochemicals for Life Science Research

Awaiting product image

Met-Enkephalin

Product ID E5241
Cas No. 58569-55-4
Purity ≥95%
Product Unit SizeCostQuantityStock
25 mg $88.10 In stock
50 mg $151.20 In stock
25 mg $88.10 In stock
125 mg $264.70 In stock
50 mg $151.20 In stock
125 mg $264.70 In stock
Bulk Quote

Quicklinks

Description

Met-enkephalin is an endogenous opioid peptide that acts as an agonist at μ-opioid receptors (μORs) and δ-opioid receptors (δORs). Met-enkephalin exhibits neuromodulatory, antinociceptive/analgesic, antidepressant, and gastrointestinal motility modulating activities. Like other endogenous opioids, met-enkephalin modulates expression of opioid receptors and plays a role in reward/reinforcement signaling. Met-enkephalin is also involved in exercise-induced reversal of neuropathic pain and in animals undergoing the forced swim test, decreases immobility time. Met-enkephalin inhibits gastrointestinal muscle contractility, inhibiting motility and gastric emptying. Additionally, analogs of this peptide display anticancer and antiepileptic/anticonvulsant activities. TEST!!!!!!

Product Info

Cas No.

58569-55-4
Purity

≥95%
Formula

C27H35N5O7S
Formula Wt.

573.67
IUPAC Name

2-[[2-[[2-[[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoic acid
Synonym

Metenkefalin, Opioid growth factor, 1-5-Adrenorphin (human)
Solubility

Soluble in 1 M HCl, water, DMSO.
Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

E5241 MSDS PDF
Info Sheet

E5241 Info Sheet PDF

References

Gonzalez-Nunez V, Jimenez González A, Barreto-Valer K, et al. In vivo regulation of the μ opioid receptor: role of the endogenous opioid agents. Mol Med. 2013 Mar 5;19:7-17. PMID: 23348513.

Fanning RA, McMorrow JP, Campion DP, et al. Opioid mediated activity and expression of mu and delta opioid receptors in isolated human term non-labouring myometrium. Eur J Pharmacol. 2013 Jan 5;698(1-3):170-7. PMID: 23051674.

Hadjiconstantinou M, Neff NH. Nicotine and endogenous opioids: neurochemical and pharmacological evidence. Neuropharmacology. 2011 Jun;60(7-8):1209-20. PMID: 21108953.

Stagg NJ, Mata HP, Ibrahim MM, et al. Regular exercise reverses sensory hypersensitivity in a rat neuropathic pain model: role of endogenous opioids. Anesthesiology. 2011 Apr;114(4):940-8. PMID: 21386701.

Gredicak M, Supek F, Kralj M, et al. Computational structure-activity study directs synthesis of novel antitumor enkephalin analogs. Amino Acids. 2010 Apr;38(4):1185-91. PMID: 19639251.

Lee HK, Smith MD, Smith BJ, et al. Anticonvulsant Met-enkephalin analogues containing backbone spacers reveal alternative non-opioid signaling in the brain. ACS Chem Biol. 2009 Aug 21;4(8):659-71. PMID: 19634861.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • V0275

    [Arg8]-Vasotocin

    Peptide, oxytocin-vasopressin analog.

    ≥95%
  • L960004

    LY-404187

    Selective positive allosteric modulator of AMPA...

    ≥98%
  • R1777

    9-cis-Retinoic Acid

    Vitamin A derivative; RAR and RXR agonist.

    ≥98%
  • B1754

    N-Benzyl-2-(6-bromo-2-methylquinolin-4-yloxy)acetamide

    ≥98%
  • M1774

    2-Mercaptoethanesulfonate Sodium

    Organosulfur, antioxidant.

    ≥98%
  • M1826

    Meglumine

    Amino sugar, sorbitol derivative, used as a bul...

    ≥98%
  • T1030

    N-Des-2-methylpropan-2-ol Docetaxel

    N-Des-2-methylpropan-2-ol Docetaxel is an impurity...
    ≥90%
  • P298576

    Phomopsin A

    ≥98%
  • A7462

    Aspartame

    Dipeptide ester, commercial sweetener.

    ≥98%
  • M1676

    Methotrexate Hydrate

    DHF reductase inhibitor.

    ≥98%
  • P1849

    Pemetrexed Disodium

    Thymidylate synthase inhibitor, potential SHMT,...

    ≥98%
  • C2970

    Chrysophanol

    Anthraquinone found in Rheum.

    ≥98%
  • D5690

    Doxazosin Mesylate

    Quinazoline; α1-adrenergic antagonist.

    ≥98%
  • W317520

    WIN 55,212-2 Mesylate

    Non-selective cannabinoid receptor agonist.

    ≥98%
  • U682042

    URB602

    Inhibitor of Monoacyglycerol lipase (MAGL).

    ≥98%
  • C4502

    Clarithromycin

    Macrolide; protein translation inhibitor.

    ≥95%
  • C1668

    Cerivastatin Sodium

    Statin; HMG-CoA reductase inhibitor.

    ≥98%
  • R3584

    Rivaroxaban

    Oxazolidone derivative; Factor Xa inhibitor.

    ≥98%
  • K624760

    KPT-276

    CRM1/XPO1 inhibitor.

    ≥99%
  • H9615

    17α-Hydroxyprogesterone Caproate

    Synthetic steroid hormone; ER antagonist.

    ≥98%